1-206637703-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003582.4(DYRK3):c.131C>T(p.Pro44Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000223 in 1,613,676 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P44A) has been classified as Uncertain significance.
Frequency
Consequence
NM_003582.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYRK3 | NM_003582.4 | c.131C>T | p.Pro44Leu | missense_variant | 2/3 | ENST00000367109.8 | NP_003573.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYRK3 | ENST00000367109.8 | c.131C>T | p.Pro44Leu | missense_variant | 2/3 | 1 | NM_003582.4 | ENSP00000356076.2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152004Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000215 AC: 54AN: 251304Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135824
GnomAD4 exome AF: 0.000233 AC: 341AN: 1461672Hom.: 1 Cov.: 30 AF XY: 0.000209 AC XY: 152AN XY: 727124
GnomAD4 genome AF: 0.000125 AC: 19AN: 152004Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74252
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 27, 2024 | The c.131C>T (p.P44L) alteration is located in exon 2 (coding exon 2) of the DYRK3 gene. This alteration results from a C to T substitution at nucleotide position 131, causing the proline (P) at amino acid position 44 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at